Skip to content
value.today
Biostate AI, Inc logo

Biostate AI, Inc

Total raised
$5 M
2 rounds on record
Latest round
$4 M
Apr 2025
First round on record
Aug 2023
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Biostate AI, Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2025$4 MNo. 2$2 to $10 million

Biostate AI, Inc: Raise no. 2, Apr 2025

Investors in this round

7 investors had bought by the notice of May 12, 2025: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $13 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ashwin Gopinath · Executive Officer, Director
  • David Zhang · Executive Officer, Director
  • Eva Miao · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Eva Y. Miao, Treasurer. Source: SEC Form D, newest notice filed May 12, 2025. Read the notice at the SEC.

equitySEC
Aug 2023$1 MNo. 1Under $2 million

Biostate AI, Inc: Raise no. 1, Aug 2023

Investors in this round

1 investor had bought by the notice of Aug 23, 2023: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $14 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ashwin Y. Gopinath · Executive Officer, Director
  • David Y. Zhang · Executive Officer, Director
  • Eva Y. Miao · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Eva Y. Miao, Treasurer. Source: SEC Form D, newest notice filed Aug 23, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Biostate AI, Inc reported revenue of $565,452 for its most recent fiscal year (filed Jul 2026), up from $66,700 the year before.

    SEC Form C/A · Jul 2026

  • The direct cost of what it sold was $690,981, so -22% of its revenue was left after those costs.

    SEC Form C/A · Jul 2026

  • Net loss for the same year: $9.88 million.

    SEC Form C/A · Jul 2026

  • Biostate AI, Inc chose not to state its revenue in its newest notice of a funding round (May 2025).

    SEC Form D · May 2025

  • The industry group it chose in its notices: Other.

    SEC Form D · May 2025

In its own words

How the company describes itself to search engines on its website, word for word.

“Biostate AI connects samples, data, and decisions to redefine precision health.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Biostate AI, Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Biostate AI, Inc
NameRoleNamed in
Ashwin GopinathExecutive officerMay 2025
David ZhangExecutive officerMay 2025
Eva MiaoExecutive officerMay 2025
Ashwin Y. GopinathExecutive officerAug 2023
David Y. ZhangExecutive officerAug 2023
Eva Y. MiaoExecutive officerAug 2023
Ashwin GopinathDirectorMay 2025
David ZhangDirectorMay 2025
Ashwin Y. GopinathDirectorAug 2023
David Y. ZhangDirectorAug 2023